# M Rovira

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/m-rovira/

## Facts

| Field | Value |
| --- | --- |
| Citations | 504 |
| Field | Hematopoietic Stem Cell Transplantation |
| h-index | 8 |
| i10-index | 7 |
| Last Known Institution | Hospital Universitari i Politècnic La Fe |
| OpenAlex ID | https://openalex.org/A5108910270 |
| Works | 29 |

## Researcher papers

- [Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study](https://scholariq.org/papers/voriconazole-for-secondary-prophylaxis-of-invasive-fungal-infections-in/)
- [MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS](https://scholariq.org/papers/mri-and-csf-oligoclonal-bands-after-autologous-hematopoietic-stem-cell/)
- [Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections](https://scholariq.org/papers/safety-of-the-concomitant-use-of-caspofungin-and-cyclosporin-a-in-patients-with/)
- [Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS](https://scholariq.org/papers/clinical-and-mri-outcome-after-autologous-hematopoietic-stem-cell/)
- [Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries](https://scholariq.org/papers/successful-treatment-of-severe-hemorrhagic-cystitis-after-hemopoietic-cell/)
- [Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients](https://scholariq.org/papers/voriconazole-as-secondary-antifungal-prophylaxis-in-stem-cell-transplant/)
- [Definitions of infectious diseases and complications after stem cell transplant](https://scholariq.org/papers/definitions-of-infectious-diseases-and-complications-after-stem-cell-transplant/)
- [Assessment of Sclerodermoid Chronic Graft-versus-host Disease with Colour Doppler Ultrasound](https://scholariq.org/papers/assessment-of-sclerodermoid-chronic-graft-versus-host-disease-with-colour/)
- [Phase I/II trials of autologous peripheral blood stem cell transplantation in autoimmune diseases resistant to conventional therapy: preliminary results from the Spanish experience](https://scholariq.org/papers/phase-i-ii-trials-of-autologous-peripheral-blood-stem-cell-transplantation-in/)
- [Pseudo-Pelger-Hüet anomaly after bone marrow transplantation.](https://scholariq.org/papers/pseudo-pelger-huet-anomaly-after-bone-marrow-transplantation/)
- [4CPS-096 Teduglutide versus home parenteral nutrition in paediatric population with short bowel syndrome](https://scholariq.org/papers/4cps-096-teduglutide-versus-home-parenteral-nutrition-in-paediatric-population/)

## Researcher topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)
- [Fungal Infections and Studies](https://scholariq.org/topics/fungal-infections-and-studies/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)

## Researcher university

- [Hospital Universitari i Politècnic La Fe](https://scholariq.org/institutions/hospital-universitari-i-politecnic-la-fe/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.